HomeCompareLOPX vs MRK

LOPX vs MRK: Dividend Comparison 2026

LOPX yields 38.51% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LOPX wins by $156.9K in total portfolio value
10 years
LOPX
LOPX
● Live price
38.51%
Share price
$5.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$213.7K
Annual income
$34,980.01
Full LOPX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LOPX vs MRK

📍 LOPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLOPXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LOPX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LOPX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LOPX
Annual income on $10K today (after 15% tax)
$3,273.07/yr
After 10yr DRIP, annual income (after tax)
$29,733.01/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, LOPX beats the other by $21,404.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LOPX + MRK for your $10,000?

LOPX: 50%MRK: 50%
100% MRK50/50100% LOPX
Portfolio after 10yr
$135.2K
Annual income
$22,389.08/yr
Blended yield
16.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LOPX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LOPX buys
0
MRK buys
0
No recent congressional trades found for LOPX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLOPXMRK
Forward yield38.51%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$213.7K$56.8K
Annual income after 10y$34,980.01$9,798.13
Total dividends collected$158.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LOPX vs MRK ($10,000, DRIP)

YearLOPX PortfolioLOPX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,551$3,850.67$11,206$366.19+$3.3KLOPX
2$20,806$5,236.43$12,650$502.35+$8.2KLOPX
3$29,260$6,997.62$14,407$694.19+$14.9KLOPX
4$40,505$9,197.17$16,585$967.82+$23.9KLOPX
5$55,239$11,898.99$19,342$1,363.89+$35.9KLOPX
6$74,272$15,165.83$22,913$1,947.19+$51.4KLOPX
7$98,528$19,057.18$27,662$2,823.89+$70.9KLOPX
8$129,052$23,627.09$34,159$4,173.35+$94.9KLOPX
9$167,008$28,922.22$43,337$6,308.80+$123.7KLOPX
10$213,679$34,980.01$56,776$9,798.13+$156.9KLOPX

LOPX vs MRK: Complete Analysis 2026

LOPXStock

The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index is an equal-weighted index provided by Solactive AG that is designed to measure the performance of U.S.-listed securities with relatively low trading prices. The fund will concentrate its investment in a particular industry or group of industries to approximately the same extent as the index is so concentrated. It is non-diversified.

Full LOPX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LOPX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LOPX vs SCHDLOPX vs JEPILOPX vs OLOPX vs KOLOPX vs MAINLOPX vs JNJLOPX vs ABBVLOPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.